Recent News About Hesperos and Human-on-a-Chip Technology

Dr. James J. Hickman elected as Fellow of the National Acadamy of Inventors!

By Hesperos | December 16, 2020 | 0 Comments

Dr. James J. Hickman elected as Fellow of the National Acadamy of Inventors Hesperos is excited to announce that Chief Scientist, Dr. James J. Hickman, has been elected fellow of the National Academy of Inventors (NAI).  … Read More

Dr. Hickman’s Presentation at AAPS about Human-On-A-Chip® technology

By Hesperos | November 20, 2020 | 0 Comments

Human-on-a-chip System for Use in Therapeutic Index Determination and Systemic Toxicity in Pre-clinical Drug Discovery Presented at AAPS 2020 by James J. Hickman, PhD Chief Scientist, Hesperos, Inc.

future tech Podcast interview with JAMES HICKMAN, PHD, Human-Based Models for Drug Testing

By Hesperos | November 19, 2020 | 0 Comments


Dr. Hickman Presents Human-on-a-Chip® at Florida Simulation Summit 2020

By Hesperos | November 9, 2020 | 0 Comments

Hesperos Chief Scientist, Dr. James Hickman discusses how a Human-on-a-Chip works at the Florida Simulation Summit 2020

Hesperos listed among 2021 Top Tech Startups in Orlando

By Hesperos | October 15, 2020 | Comments Off on Hesperos listed among 2021 Top Tech Startups in Orlando

The Tech Tribune, the journalistic arm of Crunchbase, recently selected Hesperos as one of the top 10 technology startups in Orlando. We are proud to be listed among the best companies in the City Beautiful. Award … Read More

ALS skeletal muscle for a pathologic role

By Hesperos | September 9, 2020 | 0 Comments

Unraveling the pathologic role of skeletal muscle in ALS A key challenge in developing effective therapies for amyotrophic lateral sclerosis has been a poor understanding of the disease pathology. To address this issue, a team of … Read More

ALS pathology investigated by UCF/Hesperos Researchers Utilizing a Human-on-a-Chip® model

By Hesperos | August 12, 2020 | 0 Comments

UCF/HESPEROS RESEARCHERS UTILIZE HUMAN-ON-A-CHIP® APPROACH TO MODEL ALS PATHOLOGY Key Findings Data supports use of functional neuromuscular junction (NMJ) system to evaluate amyotrophic lateral sclerosis pathology  First study to validate the use of Deanna protocol in … Read More